P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.
about
Purinergic Receptors: Key Mediators of HIV-1 Infection and InflammationPurinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapyP2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor InteractionsPutative roles of purinergic signaling in human immunodeficiency virus-1 infectionHigh-Throughput HIV-Cell Fusion Assay for Discovery of Virus Entry InhibitorsSyncytial apoptosis signaling network induced by the HIV-1 envelope glycoprotein complex: an overview.IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection.HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapyMeasuring T Cell-to-T Cell HIV-1 Transfer, Viral Fusion, and Infection Using Flow Cytometry.The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
P2860
Q26774666-9177884C-5CA1-407E-9661-6BA5AF1A18BFQ26797749-AF265B0D-4F3D-4E23-9DAD-B96E848762B9Q27321418-05E35ADF-F6BB-4116-AA12-066A164788D8Q34446486-702BEB1B-3D7B-4316-80C0-84FDBBF1C436Q35600803-BCC1C67E-9773-4F74-B1F3-283C11878AC6Q36022247-652BB3B2-5945-455A-8EC7-970C681D6993Q36150469-819D5F36-289E-4F43-BCA5-2AE0CBEF550EQ37727159-2F5CA55F-F4E1-41B5-9056-39D8A668EB5BQ38376002-AF755364-D3EF-4E97-B0E8-5D6CED15B9C0Q40852789-DEF25671-662F-40CC-B64C-8525FE1BA722Q50202418-A16800A3-BA3D-41B6-B763-6F78D7460DFD
P2860
P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
P2X-selective purinergic antag ...... -cell and cell-free infection.
@ast
P2X-selective purinergic antag ...... -cell and cell-free infection.
@en
P2X-selective purinergic antag ...... -cell and cell-free infection.
@nl
type
label
P2X-selective purinergic antag ...... -cell and cell-free infection.
@ast
P2X-selective purinergic antag ...... -cell and cell-free infection.
@en
P2X-selective purinergic antag ...... -cell and cell-free infection.
@nl
prefLabel
P2X-selective purinergic antag ...... -cell and cell-free infection.
@ast
P2X-selective purinergic antag ...... -cell and cell-free infection.
@en
P2X-selective purinergic antag ...... -cell and cell-free infection.
@nl
P2860
P50
P356
P1433
P1476
P2X-selective purinergic antag ...... -cell and cell-free infection.
@en
P2093
Anthony M Esposito
Natasha D Durham
P2860
P304
11504-11515
P356
10.1128/JVI.01158-14
P407
P577
2014-07-16T00:00:00Z